Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Recall Roundup: tainted heparin, glass flakes, odorous bottles and more

This article was originally published in The Gold Sheet

Executive Summary

Economically motivated adulteration, glass flakes in vials, out-of-specification transdermal patches, malodorous bottles and prefilled syringe sterility were among the more significant manufacturing quality issues leading to drug recalls in the past three months.

You may also be interested in...



Poor Handling of Complaints, Contractors, Contamination Draw FDA Warning Letters

Several warning letters FDA issued in January and February highlighted complaint handling issues, supply chain considerations and contamination-related concerns.

Poor Handling of Complaints, Contractors, Contamination Draw FDA Warning Letters

Several warning letters FDA issued in January and February highlighted complaint handling issues, supply chain considerations and contamination-related concerns.

August Drug Recalls

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS000563

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel